Roche partners with Chai Discovery to deploy Chai-3 model across its pipelines
Roche and Chai Discovery announced on 5 November that the Chai-3 model will be deployed across Roche's global therapeutic pipelines. The deal extends Chai's run of AI drug discovery agreements.
Who is affected and how
- pharmaceuticals
- Another example of large companies integrating external AI molecule-design platforms into their in-house pipelines.
Sources
- Chai's AI dealmaking streak rolls on with Roche drug discovery pactfirstword pharma · Nov 5, 2026
- Chai Discovery Announces Collaboration with Roche in AI-Driven Drug Discoverybusiness wire · Nov 5, 2026
- Chai Discovery, Roche to Collaborate on AI Drug Discoverycontract pharma · Nov 6, 2026
- Roche taps Chai Discovery's AI models for drug discovery programsallsci · Nov 6, 2026
- Chai Discovery, Roche to Collaborate on AI Drug Discovery | Contract Pharmacontractpharma.com · Nov 6, 2026
- Chai Adds Roche to Its Expanding AI Drug Discovery Network - Pharmacallypharmacally.com · Nov 6, 2026
- Chai Discovery Announces Collaboration with Roche in AI-Driven Drug Discovery - BioSpacebiospace.com · Nov 6, 2026
- Roche Partners with Chai Discovery to Deploy Chai-3 Across Global Therapeutic Pipelines - HIT Consultanthitconsultant.net · Nov 5, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.